Nda on Top 10Does anyone know when the NDA would typically expire with this Top 10 company that co-funded the trial as they were interested in the 0.4% formulation? It seems like a reasonable time frame to make a decision has happened but I am not an expert on these matters.
Question for the pharma experts: if the NDA period is over, and the results of the 0.4% clinical trial are considered very good/material in nature (which based upon the previous news release indicated), would they be required to disclose these further details of the trial with shareholders or no?
If they had term sheets in their posession, will these also be relevant for release as well?
Keeping us all in the dark here is certainly not helpful for the share price, at least if they are working on some great items. If they want people to reinvest on the market, then new information or insight is needed, at least to make a semi-informed decision.
In the very least, we will have more information from the CEO in a week or two.